Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.2700
-0.0272 (-9.15%)
At close: Jul 11, 2025, 4:00 PM
0.2656
-0.0044 (-1.63%)
After-hours: Jul 11, 2025, 7:54 PM EDT
Renovaro Market Cap
Renovaro has a market cap or net worth of $46.47 million as of July 11, 2025. Its market cap has decreased by -80.43% in one year.
Market Cap
46.47M
Enterprise Value
52.42M
1-Year Change
-80.43%
Ranking
Category
Stock Price
$0.27
Market Cap Chart
Since December 11, 2018, Renovaro's market cap has decreased from $252.00M to $46.47M, a decrease of -81.56%. That is a compound annual growth rate of -22.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 46.50M | -64.96% |
| Dec 31, 2024 | 132.70M | -37.23% |
| Dec 29, 2023 | 211.40M | 287.89% |
| Dec 30, 2022 | 54.50M | -85.68% |
| Dec 31, 2021 | 380.70M | 176.67% |
| Dec 31, 2020 | 137.60M | -40.77% |
| Dec 31, 2019 | 232.30M | -8.25% |
| Dec 31, 2018 | 253.20M | 0.48% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.45B |
| Johnson & Johnson | 376.02B |
| AbbVie | 336.71B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 274.78B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.78B |
| AstraZeneca | 218.25B |